• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[静脉注射达朗津作为提高失血性休克晚期血液回输效果的一种方法]

[Intravenous dalargin as a method of increasing the effectiveness of blood reinfusion in the late stages of hemorrhagic shock].

作者信息

Sherman D M, Trach V M

出版信息

Gematol Transfuziol. 1993 Sep-Oct;38(8):27-30.

PMID:8307301
Abstract

Acute experiments on 63 adult rabbits have shown that acute divided blood loss for 5 min (27 +/- 1% of the whole blood volume) results in the development of reversible hemorrhagic shock with survival of all the animals. In the same volume of continuous blood exfusion (27 +/- 5% of blood volume) or an increase in blood loss to 43 +/- 2% of blood volume hemorrhagic shock proved irreversible. Early reinfusion of heparinized blood saved all the animals, whereas late reinfusions only prolonged the survival. Intravenous administration of dalargin (0.1 mg/kg) in late shock was not effective and all the animals died. Dalargin introduction after blood reinfusion in late shock saved the animals lives. The conclusion is made on benefits of intravenous dalargin for raising the efficacy of reinfusions (hemotransfusion) at late stages of severe hemorrhagic shock.

摘要

对63只成年兔进行的急性实验表明,5分钟内急性分次失血(占全血量的27±1%)会导致可逆性失血性休克,所有动物均存活。同等血量的持续输血(占血量的27±5%)或失血量增加至占血量的43±2%时,失血性休克被证明是不可逆的。早期输注肝素化血液可挽救所有动物,而晚期输注仅能延长存活时间。晚期休克时静脉注射达拉根(0.1毫克/千克)无效,所有动物均死亡。晚期休克输血后注射达拉根可挽救动物生命。得出的结论是,静脉注射达拉根有利于提高严重失血性休克晚期再输注(输血)的疗效。

相似文献

1
[Intravenous dalargin as a method of increasing the effectiveness of blood reinfusion in the late stages of hemorrhagic shock].[静脉注射达朗津作为提高失血性休克晚期血液回输效果的一种方法]
Gematol Transfuziol. 1993 Sep-Oct;38(8):27-30.
2
[The reinfusion of blood and the administration of dalargin in experimental hemorrhagic shock].[实验性失血性休克中血液回输及达腊argin的应用] (注:dalargin可能有误,若为其他准确药物名应进行相应准确翻译,这里按原文直接译出)
Klin Khir (1962). 1994(9):38-41.
3
[Effect of intravenous administration of dalargin on the course and outcome of the body's response to acute massive hemorrhage].[静脉注射达拉根对机体对急性大量出血反应过程及结果的影响]
Patol Fiziol Eksp Ter. 1995 Apr-Jun(2):30-2.
4
[Effects of naloxone, nalorphine and dalargin on the course of shock due to the combination of mechanical trauma and acute blood loss].[纳洛酮、烯丙吗啡和达明对机械创伤与急性失血合并所致休克病程的影响]
Patol Fiziol Eksp Ter. 2004 Apr-Jun(2):11-4.
5
[Effect of dalargin on energy metabolism of heart contractile function in acute blood loss].[达拉argin对急性失血时心脏收缩功能能量代谢的影响]
Patol Fiziol Eksp Ter. 1991 Jan-Feb(1):11-2.
6
[Effects of agonists of opiate receptors on myocardial energetics of rats with hemorrhagic shock].[阿片受体激动剂对失血性休克大鼠心肌能量代谢的影响]
Biull Eksp Biol Med. 1991 May;111(5):469-71.
7
Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections.纳米颗粒作为一种能够透过血脑屏障的药物载体系统,可使静脉注射达来替丁产生中枢镇痛作用。
Brain Res. 1996 Feb 26;710(1-2):121-4. doi: 10.1016/0006-8993(95)01375-x.
8
[Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man].[脑啡肽类似物达乐argin在人体中的药代动力学的放射免疫和放射受体研究]
Biull Eksp Biol Med. 1986 Jun;101(6):702-4.
9
[The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].[对达来argin治疗颌面部急性化脓性炎症过程疗效的临床实验室评估] (注:dalargin这个词在医学领域没有准确对应的通用中文术语,这里按音译处理为“达来argin”,你可根据实际情况进行修正,如果它是某种特定药物等有固定中文名称则应使用准确名称)
Sov Med. 1991(7):29-31.
10
Early treatment with ACTH-(1-24) in a rat model of hemorrhagic shock prolongs survival and extends the time-limit for blood reinfusion to be effective.在失血性休克大鼠模型中,早期使用促肾上腺皮质激素(1-24)进行治疗可延长生存期,并延长输血有效的时间限制。
Crit Care Med. 1990 Aug;18(8):862-5. doi: 10.1097/00003246-199008000-00014.